- Investigator
- Michael D Schweitzer Barrios
- Ages
- 40 Years - 80 Years
- Sexes
- All
Clinical trials
-
Phase III Study to Evaluate the Efficacy and Safety of Tezepelumab in Adult Participants with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (JOURNEY) -
A Phase 2 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Safety and Efficacy of Oral Brepocitinib in Adults with Cutaneous Sarcoidosis - Ages
- 18 Years - 75 Years
- Sexes
- All
-
A Randomized, Double-blind, Placebo-controlled, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (20210052) - Investigator
- Vandana K Seeram
- Ages
- 40 Years - 99 Years
- Sexes
- All
-
Phase III, randomized, double-blind, placebo-controlled study to assess BI 1291583 2.5 mg once daily for up to 76 weeks in patients with bronchiectasis - Investigator
- Michael D Schweitzer Barrios
- Ages
- 18 Years - 99 Years
- Sexes
- All
-
A Phase 1 Study of EG-70 as an Intravesical Administration to Patients with BCG -Unresponsive NMIBC - Investigator
- Mark G Bandyk
- Ages
- 18 Years - 101 Years
- Sexes
- All
-
A Randomized Open-Label Phase 3 Study of XL092 + Nivolumab vs Sunitinib in Subjects with Advanced or Metastatic Non-Clear Cell Renal Cell Carcinoma - Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
A Phase 1/2 Study of EG-70 as an Intravesical Administration to Patients with BCG-Unresponsive NMIBC and High-Risk NMIBC who are BCG Na簿ve/Received Incomplete BCG Treatment - Investigator
- Kethandapatti Balaji
- Ages
- 18 Years - 100 Years
- Sexes
- All
-
Validation of Ovarian Adnexal Mass Assessment Score Test System - Investigators
- Isidore D Benrubi, Karina E Hew
- Ages
- 18 Years - 99 Years
- Sexes
- Female